Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 9/2021

01-09-2021 | Concise Research Report

Physician Factors Associated with Inappropriate Vitamin B12 Prescribing in Ontario, Canada

Authors: William K. Silverstein, MD, Yulia Lin, MD, FRCPC, Christoffer Dharma, MSc, Ruth Croxford, MSc, Matthew C. Cheung, MD, SM, FRCPC

Published in: Journal of General Internal Medicine | Issue 9/2021

Login to get access

Excerpt

Nearly two-thirds of Ontarians over the age of 65 are prescribed parenteral vitamin B12 without biochemical evidence of B12 deficiency in the year preceding their first prescription, costing an estimated $46 million CAD.1 To our knowledge, there is no published literature characterizing physician factors associated with inappropriate B12 prescribing. We assessed this using population-based databases. …
Literature
1.
Silverstein WK, Lin Y, Dharma CD, et al. Prevalence of inappropriateness of parenteral vitamin B12 administration in Ontario, Canada. JAMA Intern Med. 2019;179:1434-6CrossRef
2.
Green R, Allen LH, Bjørke-Monsen AL, et al. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017;3:17040.CrossRef
3.
Dhalla IA, Anderson GM, Mamdani MM, et al. Inappropriate prescribing before and after nursing home admission. J Amer Geriatr Soc. 2002;50:995-1000.CrossRef
4.
Berthold HK, Gouni-Berthold I, Bestehorn KP, Böhm M, Krone W. Physician gender is associated with the quality of type 2 diabetes care. J Intern Med. 2008;264:340-350.CrossRef
5.
Graham ID, Jette N, Tetroe J, Robinson N, Milne S, Mitchell SL. Oral cobalamin remains medicine’s best kept secret. Arch Gerontol Geriatr. 2007:44:49-59.CrossRef
6.
Silverstein WK, Lin Y, Cheung MC. Vitamin B12 therapy in older adults and misconception of its inappropriateness – In Reply. JAMA Intern Med. 2019;179:1606-1607.CrossRef
Metadata
Title
Physician Factors Associated with Inappropriate Vitamin B12 Prescribing in Ontario, Canada
Authors
William K. Silverstein, MD
Yulia Lin, MD, FRCPC
Christoffer Dharma, MSc
Ruth Croxford, MSc
Matthew C. Cheung, MD, SM, FRCPC
Publication date
01-09-2021
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 9/2021
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06185-3

Other articles of this Issue 9/2021

Journal of General Internal Medicine 9/2021 Go to the issue

Original Research

Medical Spanish in US Medical Schools: a National Survey to Examine Existing Programs

Original Research

Randomized Controlled Trial of a Decision Support Intervention About Cardiopulmonary Resuscitation for Hospitalized Patients Who Have a High Risk of Death

Original Research

The Joys and Challenges of Delivering Obesity Care: a Qualitative Study of US Primary Care Practices

Clinical Image

Spontaneous Pneumomediastinum in a Patient with COVID-19 Pneumonia

Letter to the Editor

Strategies for Reimagining Complex Care

Viewpoint

Overzealous Women’s Health Screening? My Story
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits